Derma Sciences, Inc. Report issue

For profit Phase 3
Founded: Princeton NJ United States (1984)
Status: Acquired by Integra LifeSciences Corporation (2017)

Organization Overview

First Clinical Trial
2008
NCT00796744
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 3 Trials (1)

aclerastide (4 trials)

Drugs in Other Trials (3)

Key: Derma Sciences, Inc. (2) Acquired (1)

collagenase clostridium histolyticum (xiaflex) (1 trial)

leptospermum honey (2 trials)

triamcinolone (kenalog) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetic Foot (Phase 3)

Foot Ulcer (Phase 3)

Ulcer (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 7
  • # of Trial APIs: 4